Medical Marijuana 411 values providing our readers with information about the latest cannabis related topics for educational purposes and not for the intention of advocacy. This is not an advocacy-based organization. For ailment specific questions, please consult your primary care physician.
An ongoing issue of particular interest to cannabis businesses is how well cannabis patents will hold up under legal scrutiny.
New Jersey legalization is expected to occur soon. Committees in the state Legislature moved a bill forward that would legalize recreational cannabis.
The first of Massachusetts recreational cannabis shops opened up on Tuesday, November 20th, 2018. Only two shops are open now but more are expected.
Deciding to change careers to join the cannabis industry? Here are insights from the VP of Operation at Medical Marijuana 411 about her switch to cannabis.
Cannabis advocates excited as four states voted on midterm cannabis legalization measures on Tuesday and Attorney General Jeff Sessions was fired Wednesday.
As businesses continue to experiment with new products and business practices, cannabis stocks have been experiencing relative volatility in recent months.
In June of 2018, the FDA approved, for the first time, a cannabis based drug. Epidiolex, is a CBD drug used to treat Dravet Syndrome.
One company making news in the cannabis community is Coca-Cola. The beverage giant has said that they are currently monitoring the cannabis beverage market.
The Canadian health department has recently announced that they will spend more than $100 million over the next six years on cannabis education.